Keywords: sanofi, starts, ph, ii, difficile, vaccine, study

Sanofi starts Ph II C. Difficile vaccine study

Article | 23 February 2009

Print This

Sanofi Pasteur, the vaccines division of leading French drugmaker Sanofi-Aventis, says it is sponsoring a Phase II clinical study of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in